跳至主要内容
临床试验/NCT01850394
NCT01850394已完成不适用

Efficacy of Low-dose Intra-articular Tranexamic Acid in Total Knee Replacement; A Prospective Triple-blinded Randomized Controlled Trial.

Mahidol University1 个研究点 分布在 1 个国家目标入组 152 人开始时间: 2010年1月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
状态
已完成
入组人数
152
试验地点
1
主要终点
Perioperative Blood Loss

研究概览

简要总结

The purpose of this study is to determine 1) the effective dosage of intra-articular tranexamic acid injection for controlling blood loss and blood transfusion requirement in conventional total knee replacement, and 2) whether the blood loss reduction effect depended on the dose of tranexamic acid used.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

入排标准

年龄范围
50 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • patients diagnosed as primary knee osteoarthritis and underwent unilateral primary cemented conventional total knee replacement
  • no risk of abnormal bleeding tendency or bleeding disorder (normal coagulogram, serum creatinine < 2.0 mg/dL, stop nonsteroidal anti-inflammatory drugs and antiplatelet drugs more than 7 days
  • no contra-indication for tranexamic acid use (no active intravascular clotting process, no acquired defective colour vision, no subarachnoid hemorrhage, no hypersensitivity to TXA, and no any of history of serious adverse effects, thrombotic disorder and hematuria)

排除标准

  • incomplete data collection, for example, malfunctioned drain or accidental drain removal.

研究组 & 干预措施

Control group

Placebo Comparator

physiologic saline 25 ml

干预措施: Physiologic saline (Drug)

TXA-250 group

Active Comparator

A total of 25-ml solution with 250-mg tranexamic acid

干预措施: Tranexamic Acid (Drug)

TXA-250 group

Active Comparator

A total of 25-ml solution with 250-mg tranexamic acid

干预措施: Physiologic saline (Drug)

TXA-500 group

Active Comparator

A total of 25-ml solution with 500-mg tranexamic acid

干预措施: Tranexamic Acid (Drug)

TXA-500 group

Active Comparator

A total of 25-ml solution with 500-mg tranexamic acid

干预措施: Physiologic saline (Drug)

结局指标

主要结局

Perioperative Blood Loss

时间窗: 5 days after surgery

* Drainage blood loss measured by accumulating total drainage volume postoperatively * Calculated total blood loss measured by using specific formula and difference between hematocrit preoperatively and the fourth postoperative day

Total Hemoglobin Loss

时间窗: 5 days after surgery

Total hemoglobin loos measured by difference between hemoglobin preoperatively and the fourth postoperative day

次要结局

  • Knee Function Scores(1 year after surgery)
  • Number of Patients Required Blood Transfusion(postoperative period (5 days after surgery))
  • Number of Patients Having Postoperative Complications(postoperative 1-year period)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Viroj Kawinwonggowit

Clinical Professor

Mahidol University

研究点 (1)

Loading locations...

相似试验